MAPT and synucleinopathy: Moreover, in α-synucleinopathies, the presence of additional tau pathology is associated with a higher cortical α-syn burden, and confers a worse prognosis related to survival and cognitive performance, as well as the interval between the onset of motor and dementia symptoms [122,126].